Results 261 to 270 of about 1,183,219 (341)

Changes in the visual evoked potential to pattern reversal with lithium medication

open access: closedElectroencephalography and Clinical Neurophysiology, 1983
Previous reports in the literature have suggested that lithium medication does not affect the VEP to flash stimulation. It was predicted that this would not be true for pattern reversal stimulation. Seven patients had their pattern evoked potential measured using a 42' check to fractional pattern displacement of 1/4, 1/2, 3/4 and full square.
P. B. C. Fenwick, Robyn Robertson
semanticscholar   +5 more sources

Recurring Nephrotic Syndrome After Lithium Medication

Journal of Clinical Psychopharmacology, 2019
Copyright © hyperlipidemia. The etiologies of NS are classified into primary renal disorders and secondary causes like drug-related NS. Lithium is an extremely rare cause for NS.
Anja Wilkening   +3 more
openaire   +3 more sources

The association of antipsychotic medication and lithium with brain measures in patients with bipolar disorder

European Neuropsychopharmacology, 2016
There is evidence that brain structure is abnormal in patients with bipolar disorder. Lithium intake appears to ׳normalise׳ global and local brain volumes, but effects of antipsychotic medication on brain volume or cortical thickness are less clear.
Roel A. Ophoff   +11 more
openaire   +5 more sources

Prophylactic Medication for Unipolar Depressive Illness: The Place of Lithium Carbonate in Combination with Antidepressant Medication

open access: closedThe Canadian Journal of Psychiatry, 1990
A meta-analysis of the controlled clinical trials comparing the efficacy of combined lithium-imipramine therapy with each drug alone in the prevention of relapse in patients with unipolar depressive illness shows the combination to be superior to lithium alone (for any relapse, p < 0.05; for specifically depressive relapse, p < 0.025) and ...
Hae R. Kim   +2 more
openalex   +4 more sources

Serotonin Syndrome after Lithium Add-on Medication to Paroxetine

open access: closedPharmacopsychiatry, 1997
A 59-year-old female patient was hospitalized on account of a depressive episode in the course of a long-standing bipolar disorder. On a combination of lithium (400 mg/day) and paroxetine (30 mg/day) she developed symptoms of shivering, high-frequency tremor of the upper and lower limbs, skin flush in the face, agitation, and slight impairment of ...
Thomas Sobanski   +3 more
openalex   +5 more sources

Double-Blind, Placebo-Controlled Trial of the Use of Lithium to Augment Antidepressant Medication in Continuation Treatment of Unipolar Major Depression

open access: closedAmerican Journal of Psychiatry, 2000
OBJECTIVE Use of lithium to augment antidepressant medication has been shown to be beneficial in the acute treatment of depression. The authors examined the efficacy of lithium augmentation in the continuation treatment of unipolar major depressive ...
Michael Bauer   +5 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy